ESC 365 - Audience Q&A - State-of-the-art-lipid treatment in coronary patients in 2017.

ESC Premium Access

Audience Q&A - State-of-the-art-lipid treatment in coronary patients in 2017.

Session: State-of-the-art lipid treatment in coronary patients in 2017

Topic: Lipids (Epidemiology and Prevention)

Speaker: Doctor M. Bonaca (Aurora, US) Professor E. Braunwald (Boston, US) Professor F. Mach (Geneva, CH)

Sponsored by MSD

Event: ESC Congress 2017

Congress Presentation

Add to my library

About the speakers

Doctor Marc Bonaca

University of Colorado Anschutz Medical Campus, Aurora (United States of America)

30 presentations

1 follower

Professor Eugene Braunwald

Brigham and Women's Hospital, Harvard Medical School, Boston (United States of America)

37 presentations

12 followers

Professor Francois Mach

University hospitals of Geneva, Geneva (Switzerland)

21 presentations

3 followers

4 more presentations in this session

A clinician's perspective on recent guidelines in clinical practice.

Speaker: Doctor M. Bonaca (Aurora, US)

State-of-the-art lipid-lowering combination therapies.

Speaker: Professor F. Mach (Geneva, CH)

Emerging science: recent evidence and science on the horizon.

Speaker: Professor E. Braunwald (Boston, US)

Successes and challenges in clinical practice.

Speaker: Doctor C. Ballantyne (Houston, US)

Access the full session

State-of-the-art lipid treatment in coronary patients in 2017

Speakers: Doctor M. Bonaca, Professor E. Braunwald, Professor F. Mach, Doctor M. Bonaca, Professor F. Mach...

About the event

ESC Congress 2017

26 August - 30 August 2017

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources